Literature DB >> 12672958

Solution structure of a functionally active fragment of decay-accelerating factor.

Stanislava Uhrinova1, Feng Lin, Graeme Ball, Krystyna Bromek, Dusan Uhrin, M Edward Medof, Paul N Barlow.   

Abstract

The second and third modules of human decay accelerating factor (DAF) are necessary and sufficient to accelerate decay of the classical pathway (CP) convertase of complement. No structure of a mammalian protein with decay-accelerating activity has been available to date. We therefore determined the solution structure of DAF modules 2 and 3 (DAF approximately 2,3). Structure-guided analysis of 24 mutants identified likely contact points between DAF and the CP convertase. Three (R96, R69, and a residue in the vicinity of L171) lie on DAF approximately 2,3's concave face. A fourth, consisting of K127 and nearby R100, is on the opposite face. Regions of module 3 remote from the semiflexible 2-3 interface seem not to be involved in binding to the CP convertase. DAF thus seems to occupy a groove on the CP convertase such that both faces of DAF close to the 2-3 junction (including a positively charged region that encircles the protein at this point) interact simultaneously. Alternative pathway convertase interactions with DAF require additional regions of CCP 3 lying away from the 2-3 interface, consistent with the established additional requirement of module 4 for alternative pathway regulation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12672958      PMCID: PMC153622          DOI: 10.1073/pnas.0730844100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Characterization of surfactant liquid crystal phases suitable for molecular alignment and measurement of dipolar couplings.

Authors:  L G Barrientos; C Dolan; A M Gronenborn
Journal:  J Biomol NMR       Date:  2000-04       Impact factor: 2.835

2.  Influence of non-bonded parameters on the quality of NMR structures: a new force field for NMR structure calculation.

Authors:  J P Linge; M Nilges
Journal:  J Biomol NMR       Date:  1999-01       Impact factor: 2.835

3.  Crystallography & NMR system: A new software suite for macromolecular structure determination.

Authors:  A T Brünger; P D Adams; G M Clore; W L DeLano; P Gros; R W Grosse-Kunstleve; J S Jiang; J Kuszewski; M Nilges; N S Pannu; R J Read; L M Rice; T Simonson; G L Warren
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-09-01

Review 4.  Measurement of J and dipolar couplings from simplified two-dimensional NMR spectra.

Authors:  M Ottiger; F Delaglio; A Bax
Journal:  J Magn Reson       Date:  1998-04       Impact factor: 2.229

5.  Solution structure and dynamics of linked cell attachment modules of mouse fibronectin containing the RGD and synergy regions: comparison with the human fibronectin crystal structure.

Authors:  V Copié; Y Tomita; S K Akiyama; S Aota; K M Yamada; R M Venable; R W Pastor; S Krueger; D A Torchia
Journal:  J Mol Biol       Date:  1998-04-03       Impact factor: 5.469

6.  Expression of the activation antigen CD97 and its ligand CD55 in rheumatoid synovial tissue.

Authors:  J Hamann; J O Wishaupt; R A van Lier; T J Smeets; F C Breedveld; P P Tak
Journal:  Arthritis Rheum       Date:  1999-04

Review 7.  Human complement regulators: a major target for pathogenic microorganisms.

Authors:  G Lindahl; U Sjöbring; E Johnsson
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

8.  Crystallization and preliminary X-ray diffraction analysis of a biologically active fragment of CD55.

Authors:  S Lea; R Powell; D Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-06

9.  Structure/function studies of human decay-accelerating factor.

Authors:  W G Brodbeck; L Kuttner-Kondo; C Mold; M E Medof
Journal:  Immunology       Date:  2000-09       Impact factor: 7.397

10.  Effects of proline cis-trans isomerization on TB domain secondary structure.

Authors:  X Yuan; J M Werner; V Knott; P A Handford; I D Campbell; K Downing
Journal:  Protein Sci       Date:  1998-10       Impact factor: 6.725

View more
  15 in total

1.  Complement regulation at the molecular level: the structure of decay-accelerating factor.

Authors:  P Lukacik; P Roversi; J White; D Esser; G P Smith; J Billington; P A Williams; P M Rudd; M R Wormald; D J Harvey; M D M Crispin; C M Radcliffe; R A Dwek; D J Evans; B P Morgan; R A G Smith; S M Lea
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

2.  The structure of C2b, a fragment of complement component C2 produced during C3 convertase formation.

Authors:  Vengadesan Krishnan; Yuanyuan Xu; Kevin Macon; John E Volanakis; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-02-20

3.  Tissue distribution and functional analysis of Sushi domain-containing protein 4.

Authors:  Zhidan Tu; Mark Cohen; Hong Bu; Feng Lin
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

4.  Molecular engineering of an efficient four-domain DAF-MCP chimera reveals the presence of functional modularity in RCA proteins.

Authors:  Hemendra Singh Panwar; Hina Ojha; Payel Ghosh; Sagar H Barage; Sunil Raut; Arvind Sahu
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-29       Impact factor: 11.205

5.  The crystal structure of a coxsackievirus B3-RD variant and a refined 9-angstrom cryo-electron microscopy reconstruction of the virus complexed with decay-accelerating factor (DAF) provide a new footprint of DAF on the virus surface.

Authors:  Joshua D Yoder; Javier O Cifuente; Jieyan Pan; Jeffrey M Bergelson; Susan Hafenstein
Journal:  J Virol       Date:  2012-09-12       Impact factor: 5.103

6.  Amino acid patterns within short consensus repeats define conserved duplicons shared by genes of the RCA complex.

Authors:  Craig A McLure; Roger L Dawkins; Joseph F Williamson; Richard A Davies; Jemma Berry; Longman-Jacobsen Natalie; Rebecca Laird; Silvana Gaudieri
Journal:  J Mol Evol       Date:  2004-08       Impact factor: 2.395

7.  Biological activity, membrane-targeting modification, and crystallization of soluble human decay accelerating factor expressed in E. coli.

Authors:  Jennifer White; Petra Lukacik; Dirk Esser; Michael Steward; Naomi Giddings; Jeremy R Bright; Sarah J Fritchley; B Paul Morgan; Susan M Lea; Geoffrey P Smith; Richard A G Smith
Journal:  Protein Sci       Date:  2004-09       Impact factor: 6.725

8.  Interaction of decay-accelerating factor with coxsackievirus B3.

Authors:  Susan Hafenstein; Valorie D Bowman; Paul R Chipman; Carol M Bator Kelly; Feng Lin; M Edward Medof; Michael G Rossmann
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

9.  Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Authors:  Vannakambadi K Ganesh; Scott A Smith; Girish J Kotwal; Krishna H M Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

10.  Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces.

Authors:  Joanne M O'Leary; Krystyna Bromek; Gordon M Black; Stanislava Uhrinova; Christian Schmitz; Xuefeng Wang; Malgorzata Krych; John P Atkinson; Dusan Uhrin; Paul N Barlow
Journal:  Protein Sci       Date:  2004-05       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.